# Hecheng

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hecheng

- Industry: Chemicals
- Headquarters: Tianjin, China
- Website: tjhecheng.com
- Total disclosed funding: $29M
- Latest round: Series B (Dec 31, 2024)
- Investors on record: 3

## About

Established in 1994 and based in Tianjin, China, Hecheng operates as an Ion exchange resin product developer dedicated to providing functional resin materials. It has branches in Nankai University and California. The company has a R&D and production centre covering an area of more than 20,000 square meters. In 2004, it acquired ISO9001 quality system certification. Hecheng has obtained 35 patents, including 6 invention patents and 29 utility model patents. In May 2024, the company raised over CNY 10 million in series A funding from new investor Bohai Securities. In December 2024, the firm raised CNY 200 million in series B funding.

The company mainly provides functional resin products, which include solid-phase synthetic carrier resin, immobilized enzyme carrier resin, medicinal adsorption resin, blood perfusion resin, chelating resin, ion exchange resin, chromatographic separation resin, and other products. The products can be used in solid-phase synthesis of peptide drugs and DNA drugs, blood perfusion, food industry, water treatment, hydrometallurgy and other fields. 

The company generates revenue by providing functional resin products.

The company will use the series B funding for capacity construction and the expansion and improvement of its talent team.

## Funding rounds

- Series B, Dec 31, 2024, $27M — Shenzhen Capital Real Estate Fund
- Series A, Dec 11, 2024 — Sinochem
- Angel, Feb 1, 2002, $1.4M — TEDA Venture Capital

## Investors

- TEDA Venture Capital (https://capitalatlas.ai/funds/teda-venture-capital) — Angel
- Sinochem (https://capitalatlas.ai/funds/sinochem) — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B